PANDRH Working Groups consist of groups of experts in areas that have been identified as priorities for drug regulatory harmonization. Members are selected by the steering committee and confirmed by the regulatory authorities of the respective countries. Whenever possible, working groups have at least one representative from each of the five sub-regional blocs of the Americas.